A股異動丨荃銀高科漲6.51% 農業部公佈一批轉基因作物生產安全證書
格隆匯12月31日丨荃銀高科(300087.SZ)漲6.51%,報10.15元,總市值43.7億元。農業農村部30日公佈了2019年農業轉基因生物安全證書(生產應用)清單和2019年農業轉基因生物安全證書(進口)清單。公佈的281個生產應用安全證書中,79個為到期續展的抗蟲棉,1個為到期續展的植物菌劑,新批准9個轉基因動物疫苗及生物製劑、189個抗蟲棉、2個抗蟲耐除草劑玉米、1個耐除草劑大豆。公佈的12個進口安全證書中,10個為到期續展的安全證書,2個新批准的進口農業轉基因生物為抗蟲大豆、抗病番木瓜。荃銀高科是一家以現代種業技術產業化為發展方向,從事雜交水稻等各類農作物種子育繁推一體化的高科技現代農業上市公司。現擁有10多家控股子公司,系“國家高新技術企業、中國種業信用明星企業、安徽省農業產業化龍頭企業、安徽省創新型企業”。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.